Pharmell Life Sciences offers a unique specialized digital platform that connects early-stage high-potential Life Sciences companies with diverse professional investors, from individual to institutional backers.
Our services offer simplified and streamlined fundraising support, providing start-ups with access to capital through a curated pool of investors. Investors have access to top-tier Life Sciences deals through stringent independent scientific and regulatory due diligence allowing meaningful à la carte investments in comparison to pooled investments.
We offer free access to exclusive investment opportunities and no investment fees. If you decide to invest, a low disruptive 3% one-off fee is charged to the company.
By exclusively targeting Life Sciences start-ups, we offer investment opportunities that are advancing cutting-edge healthcare solutions and contributing to life-changing innovations. This specialization means deeper expertise in scientific and regulatory aspects and more relevant investment opportunities, especially in high-impact sectors like cancer research and biotechnology.
Start-ups are rigorously evaluated and chosen based on their scientific innovation, market potential, and financial viability. This allows investors to select from a curated list of high-quality companies, ensuring that each project aligns with their interests and risk appetite. Investors can build their own tailored portfolio over time and diversify across stages.
We follow stringent independent scientific and regulatory due diligence processes governed by a robust Quality Management System. This ensures that only the most promising and viable companies make it onto the platform, providing confidence to investors in the integrity of their investments.
Pharmell Life Sciences democratizes access to premier Life Sciences investment deals traditionally limited to large institutional investors. By leveraging our extensive network, early-stage companies gain access to qualified individual, professional, and institutional investors.
Pharmell Life Sciences services
We believe that we should not earn a portion of your profit based on the performance of the company as you are taking the financial risk. That is why we do not charge an additional fee upon a successful exit.
As an investor via Pharmell Life Sciences, you pay no membership fees, no investment fees, and no due diligence fees. If you decide to invest, a low 3% one-off fee is charged to the company.